Highly Sensitive Time-Resolved Fluorescence Platform for POCT PRECISIONBIOSENSOR ExdioTRF Plus Precision Biosensor E-mail [email protected] www.precision-bio.com
Open the catalog to page 1Advanced Fluorescence Immunoassay Analyzer Exdia TRF Plus analyzer is a reliable, simple and compact immunoassay analyzer based on Time-Resolved Fluorescence technology providing accurate and fast results near the point of patient care. Core Capabilities • Lab Quality • High Sensitivity High sensitivity based on advanced TRF including own technology Lab Precision High correlation with laboratory method Quality Control Quality control and system check • Easy & Fast • Product Code
Open the catalog to page 2TRF eliminates auto-fluorescence and interference signal by measuring the emitted fluorescence signal with excitation light turned off. Signal Comparison of FluoresceneVSTRF Detection with Exitation Light ON (Fluorescence-based Technology) I Improvement of SNR (Signal to Noise Ratio) | Detection with Exitation Light OFF (TRF Technology) • Exploration of TRF sensitivity using Exdia Tnl Discrimination of 3.3 pg/mLfrom 2.0 pg/mL (in comparison with Architect Tnl, Abbott) Create Solutions for Better Care - Better Life The Exdia Troponin I test is a time resolved fluorescence immuno-chromatography...
Open the catalog to page 3Exdia D-dimer Exdia 3 in 1 (Tnl, CK-MB, Myo) The Exdia D-dimer Test is a time resolved fluorescence immuno-chromatography assay for the quantitative determination of D-dimer in human whole blood and plasma specimen with Exdia TRF analyzer. The test is used as an aid in the diagnosis of Disseminated Intravascular Coagulation (DIC) or Venous Thromboembolism (VTE), which includes Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE). * Correlation study The Exdia 3-in-1 test is a time resolved fluorescence immuno-chromatography assay for the quantitative determination of Troponin I (Tnl), Creatine...
Open the catalog to page 4Exdia Immunochemical Fecal Occult Blood (iFOB) The Exdia PCT Test is a FIA {Fluorescence Immunoassay) using TRF technology for the quantitative determination of PCT (Procalcitonin) level in human whole blood, serum and plasma specimens for patients who may have systemic or severe bacterial infection including bacterial pneumonia and bacterial meningitis. As an aid in the diagnosis of individuals suspected of sepsis, PCT test should be ordered along with other tests such as a CRP (C-reactive protein), blood culture, CBC (Complete Blood Count), or CSF (cerebrospinal fluid) analysis. * Correlation...
Open the catalog to page 5Exdia Influenza A+B Exdia TSH is in vitro diagnostic device utilizes Time-Resolved Fluorescence (TRF) immunological analysis to quantify The Exdia Influenza A+B test is a time resolved fluorescence immunoassay for the qualitative determination of influenza A and influenza B viral nucleoprotein antigens from nasopharyngeal secretion specimens in symptomatic patients. This qualitative test is intended for use as an aid in the rapid differential diagnosis of influenza A and influenza B viral infections. * Exdia Influenza A+B in comparison with RT-PCR 20 Test cartridges, 2 Extraction buffers (buffer...
Open the catalog to page 6Exdia COVID Flu Ag Combo The Exdia Vitamin D test is a fluorescence immunoassay for the quantitative determination of vitamin D (total 25(0H)D2/D3) in human serum and plasma (EDTA, lithium-heparin, and citrate). Measurements of total 25(0H)D2/D3 are used to aid in the assessment of vitamin D sufficiency. Exdia C0V1D Flu Ag Combo is a time-resolved fluorescence immunoassay that is used with the Exdia TRF analyzer intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 or Influenza A/B in nasopharyngeal swab from individuals who are suspected of COVID-19 or Influenza...
Open the catalog to page 7PBCheck COVID-19 AgThe PBCheck COVID-19 Ag is a rapid immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab from individuals who are suspected of COVID-19 their healthcare provider. The results are for the identification of SARS-CoV-2 nucleocapsid protein antigen.• Clinical performance study Comparison Test • Positive Percent Agreement (PPA, %) = (90/100) x 100 = 90.096 (Wilson 9596 Cl: 82.6-94.5) • Negative Percent Agreement (NPA, 96) = (108/108) x 100 = 10096 (Wilson 95% Cl: 96.6-100) WB: Whole blood, P; Plasma, S: Serum...
Open the catalog to page 8